Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00851084
What this trial is testing

Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 268
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750848
What this trial is testing

Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer

Who this might be right for
Advanced Breast Cancer
Jundong Wu 48
Early research (Phase 1)Ended earlyNCT00630318
What this trial is testing

Testing New Method of Analyzing MR Images

Who this might be right for
Breast Abnormalities
Indiana University 12
Early research (Phase 1)Study completedNCT02443324
What this trial is testing

Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionNon-small Cell Lung Cancer+2 more
Eli Lilly and Company 175
Testing effectiveness (Phase 2)Active Not RecruitingNCT03851614
What this trial is testing

Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors

Who this might be right for
Mismatch Repair Proficient Colorectal CancerPancreatic AdenocarcinomaLeiomyosarcoma
University Health Network, Toronto 90
Not applicableUnknownNCT04639284
What this trial is testing

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06255392
What this trial is testing

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Who this might be right for
Fludzoparib" and Anti-angiogenicHRD-positive/HER2-negative Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Large-scale testing (Phase 3)Study completedNCT00561470
What this trial is testing

Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 1,226
Not applicableStudy completedNCT00728598
What this trial is testing

Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis

Who this might be right for
Proliferative Diabetic RetinopathyAngiogenesis
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01441414
What this trial is testing

PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 18
Not applicableUnknownNCT04851054
What this trial is testing

Postoperative VEGF and Recurrence After Colon Cancer Surgery

Who this might be right for
AngiogenesisColon CancerSurgery+2 more
Hospital del Mar 280
Large-scale testing (Phase 3)Study completedNCT01235962
What this trial is testing

Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma (RCC)Cancer
Novartis Pharmaceuticals 1,538
Not applicableWithdrawnNCT03244969
What this trial is testing

Bone Healing Study

Who this might be right for
Bone Fracture
Kazan Federal University
Testing effectiveness (Phase 2)Looking for participantsNCT07359053
What this trial is testing

MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

Who this might be right for
Sarcoma
Shanghai 6th People's Hospital 46
Testing effectiveness (Phase 2)Study completedNCT03162588
What this trial is testing

Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya

Who this might be right for
Ischemic AttackIschemic StrokeMoyamoya Disease+2 more
Ajou University School of Medicine 37
Testing effectiveness (Phase 2)Study completedNCT01620970
What this trial is testing

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of Bladder
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Testing effectiveness (Phase 2)Ended earlyNCT01807156
What this trial is testing

Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular Cancer
Emory University 7
Early research (Phase 1)Study completedNCT00870532
What this trial is testing

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Centre, Singapore 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314372
What this trial is testing

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)Liver Cancer Adult
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 86
Large-scale testing (Phase 3)UnknownNCT02748772
What this trial is testing

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Who this might be right for
Colorectal Neoplasms
The First People's Hospital of Hefei 148
Next Page